RXRX holder plans 100,000-share Class A sale
Recursion Pharmaceuticals, Inc. (RXRX) filed a notice covering a proposed sale of 100,000 Class A shares through Fidelity Brokerage Services LLC on or after July 13, 2026.
Rhea-AI Filing Summary
Recursion Pharmaceuticals, Inc. (RXRX) filed a notice covering a proposed sale of 100,000 Class A shares through Fidelity Brokerage Services LLC on or after July 13, 2026. These are noted as founders shares originally acquired on April 20, 2021 as compensation.
The filing also lists multiple recent Class A share sales over the past three months by Christopher C. Gibson, the Gibson Family Trust, and Lahwran-3 LLC, with individual transactions ranging from 40,000 to 340,440 shares and corresponding dollar amounts disclosed for each sale.
Positive
- None.
Negative
- None.
Filing Explained
A holder may dispose of 100,000 shares, while the filing reports neither completed execution nor new shares issued by Recursion.
The
The filing identifies these shares as acquired from the issuer on
AI-generated analysis. How Rhea-AI works. Not financial advice.